Search

Objectives: This study aimed to elucidate the mechanisms of chiropractic care using resting electroencephalography (EEG), somatosensory evoked potentials (SEPs), clinical health assessments (Fitbit), and Patient-reported Outcomes Measurement Information System (PROMIS-29). Methods: Seventy-six people with chronic low back pain (mean age ± SD: 45 ± 11 years, 33 female) were randomised into control (n = 38) and chiropractic (n = 38) groups. EEG and SEPs were collected pre and post the first intervention and post 4 weeks of intervention. PROMIS-29 was measured pre and post 4 weeks. Fitbit data were recorded continuously. Results: Spectral analysis of resting EEG showed a significant increase in Theta, Alpha and Beta, and a significant decrease in Delta power in the chiropractic group post intervention. Source localisation revealed a significant increase in Alpha activity within the Default Mode Network (DMN) post intervention and post 4 weeks. A significant decrease in N30 SEP peak amplitude post intervention and post 4 weeks was found in the chiropractic group. Source localisation demonstrated significant changes in Alpha and Beta power within the DMN post-intervention and post 4 weeks. Significant improvements in light sleep stage were observed in the chiropractic group along with enhanced overall quality of life post 4 weeks, including significant reductions in anxiety, depression, fatigue, and pain. Conclusions: These findings indicate that many health benefits of chiropractic care are due to altered brain activity. [ABSTRACT FROM AUTHOR]

Objectives: In this study, we explored the effects of chiropractic spinal adjustments on resting-state electroencephalography (EEG) recordings and early somatosensory evoked potentials (SEPs) in Alzheimer's and Parkinson's disease. Methods: In this randomized cross-over study, 14 adults with Alzheimer's disease (average age 67 ± 6 years, 2 females:12 males) and 14 adults with Parkinson's disease (average age 62 ± 11 years, 1 female:13 males) participated. The participants underwent chiropractic spinal adjustments and a control (sham) intervention in a randomized order, with a minimum of one week between each intervention. EEG was recorded before and after each intervention, both during rest and stimulation of the right median nerve. The power-spectra was calculated for restingstate EEG, and the amplitude of the N30 peak was assessed for the SEPs. The source localization was performed on the power-spectra of resting-state EEG and the N30 SEP peak. Results: Chiropractic spinal adjustment significantly reduced the N30 peak in individuals with Alzheimer's by 15% (p = 0.027). While other outcomes did not reach significance, resting-state EEG showed an increase in absolute power in all frequency bands after chiropractic spinal adjustments in individuals with Alzheimer's and Parkinson's disease. The findings revealed a notable enhancement in connectivity within the Default Mode Network (DMN) at the alpha, beta, and theta frequency bands among individuals undergoing chiropractic adjustments. Conclusions: We found that it is feasible to record EEG/SEP in individuals with Alzheimer's and Parkinson's disease. Additionally, a single session of chiropractic spinal adjustment reduced the somatosensory evoked N30 potential and enhancement in connectivity within the DMN at the alpha, beta, and theta frequency bands in individuals with Alzheimer's disease. Future studies may require a larger sample size to estimate the effects of chiropractic spinal adjustment on brain activity. Given the preliminary nature of our findings, caution is warranted when considering the clinical implications. Clinical Trial Registration: The study was registered by the Australian New Zealand Clinical Trials Registry (registration number ACTRN12618001217291 and 12618001218280). [ABSTRACT FROM AUTHOR]

This study examines the performance of various machine learning (ML) models in predicting Interstitial Glucose (IG) levels using data from wrist-worn wearable sensors. The insights from these predictions can aid in understanding metabolic syndromes and disease states. A public dataset comprising information from the Empatica E4 smart watch, the Dexcom Continuous Glucose Monitor (CGM) measuring IG, and a food log was utilized. The raw data were processed into features, which were then used to train different ML models. This study evaluates the performance of decision tree (DT), support vector machine (SVM), Random Forest (RF), Linear Discriminant Analysis (LDA), K-Nearest Neighbors (KNN), Gaussian Naïve Bayes (GNB), lasso cross-validation (LassoCV), Ridge, Elastic Net, and XGBoost models. For classification, IG labels were categorized into high, standard, and low, and the performance of the ML models was assessed using accuracy (40–78%), precision (41–78%), recall (39–77%), F1-score (0.31–0.77), and receiver operating characteristic (ROC) curves. Regression models predicting IG values were evaluated based on R-squared values (−7.84–0.84), mean absolute error (5.54–60.84 mg/dL), root mean square error (9.04–68.07 mg/dL), and visual methods like residual and QQ plots. To assess whether the differences between models were statistically significant, the Friedman test was carried out and was interpreted using the Nemenyi post hoc test. Tree-based models, particularly RF and DT, demonstrated superior accuracy for classification tasks in comparison to other models. For regression, the RF model achieved the lowest RMSE of 9.04 mg/dL with an R-squared value of 0.84, while the GNB model performed the worst, with an RMSE of 68.07 mg/dL. A SHAP analysis identified time from midnight as the most significant predictor. Partial dependence plots revealed complex feature interactions in the RF model, contrasting with the simpler interactions captured by LDA. [ABSTRACT FROM AUTHOR]

Despite most episodes of low back pain (LBP) being short-lasting, some transition into persistent long-lasting problems. Hence, the need for a deeper understanding of the physiological mechanisms of this is pertinent. Therefore, the aims of the present study are (1) to map pain-induced changes in brain activity and blood gene expression associated with persistent LBP, and (2) to explore whether these brain and gene expression signatures show promise as predictive biomarkers for the development of persistent LBP. The participants will be allocated into three different pain groups (no pain, mild short-lasting, or moderate long-term). One in-person visit, where two blood samples will be collected and sent for RNA sequencing, along with resting 64-channel electro-encephalography measurements before, during, and after a cold pressor test, will be conducted. Thereafter, follow-up questionnaires will be distributed at 2 weeks, 3 months, and 6 months. Recruitment will start during the second quarter of 2024, with expected completion by the last quarter of 2024. The results are expected to provide insight into the relationship between central nervous system activity, gene expression profiles, and LBP. If successful, this study has the potential to provide physiological indicators that are sensitive to the transition from mild, short-term LBP to more problematic, long-term LBP. [ABSTRACT FROM AUTHOR]